Skip to main content

Advertisement

Log in

Psychiatric Symptoms, Salivary Cortisol and Cytokine Levels in Young Marijuana Users

  • ORIGINAL ARTICLE
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

Psychological maturation continues into young adulthood when substance abuse and several psychiatric disorders often emerge. Marijuana is the most common illicit drug abused by youths, typically preceding other illicit substances. We aimed to evaluate the complex and poorly studied relationships between marijuana use, psychiatric symptoms, and cortisol levels in young marijuana users. Psychiatric symptoms and salivary cortisol were measured in 122 youths (13–23 years old) with and without marijuana use. Psychiatric symptoms were evaluated using the Symptom-Checklist-90-R and Brief Psychiatric Rating Scale. Mid-day salivary cortisol levels were measured. Additionally, salivary cytokine levels were measured in a subset of participants. Although the cortisol levels and salivary cytokine levels were similar, the young marijuana users had more self-reported and clinician rated psychiatric symptoms than controls, especially anxiety-associated symptoms. Moreover, marijuana users with earlier age of first use had more symptoms, while those with longer abstinence had fewer symptoms. Greater cumulative lifetime marijuana use was also associated with greater psychiatric symptoms. The discordant anxiety (feeling stressed or anxious despite normal cortisol) in the marijuana users, as well as symptom exacerbations with early and continued marijuana use in young marijuana users suggest that marijuana use may contribute to an aberrant relationship between stress response and psychiatric symptoms. The greater symptomatology, especially in those with earlier initiation and greater marijuana usage, emphasize the need to intervene for substance use and perceived anxiety in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • ABCD (2014) Adolescent brain cognitive development study. (NIAAA, NIDA, & NCI): U.S. DHHS. http://addictionresearch.nih.gov/adolescent-brain-cognitive-development-study

  • Adam EK (2006) Transactions among adolescent trait and state emotion and diurnal and momentary cortisol activity in naturalistic settings. Psychoneuroendocrinology 31:664–679

    Article  CAS  PubMed  Google Scholar 

  • Armario A (2010) Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharmacol Sci 31:318–325

    Article  CAS  PubMed  Google Scholar 

  • Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325:1212–1213

    Article  PubMed Central  PubMed  Google Scholar 

  • Berdyshev EV, Boichot E, Germain N, Allain N, Anger JP, Lagente V (1997) Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur J Pharmacol 330:231–240

    Article  CAS  PubMed  Google Scholar 

  • Block RI, Farinpour R, Schlechte JA (1991) Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend 28:121–128

    Article  CAS  PubMed  Google Scholar 

  • Caballero A, Tseng KY (2012) Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia. Front Pharmacol 3:101

    Article  PubMed Central  PubMed  Google Scholar 

  • Cabral GA (2006) Drugs of abuse, immune modulation, and AIDS. J Neuroimmune Pharmacol 1:280–295

    Article  PubMed  Google Scholar 

  • Chang L, Yakupov R, Cloak C, Ernst T (2006) Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain 129:1096–1112

    Article  CAS  PubMed  Google Scholar 

  • Cloak CC, Alicata D, Chang L, Andrews-Shigaki B, Ernst T (2011) Age and sex effects levels of choline compounds in the anterior cingulate cortex of adolescent methamphetamine users. Drug Alcohol Depend 119:207–215

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Degenhardt L, Hall W, Lynskey M (2003) Exploring the association between cannabis use and depression. Addiction 98:1493–1504

    Article  PubMed  Google Scholar 

  • DeSantis AS, DiezRoux AV, Hajat A, Aiello AE, Golden SH, Jenny NS, Seeman TE, Shea S (2012) Associations of salivary cortisol levels with inflammatory markers: the Multi-Ethnic Study of Atherosclerosis. Psychoneuroendocrinology 37:1009–1018

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Fergusson DM, Horwood LJ (2000) Does cannabis use encourage other forms of illicit drug use? Addiction 95:505–520

    Article  CAS  PubMed  Google Scholar 

  • Fokos S, Panagis G (2010) Effects of delta9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress. J Psychopharmacol 24:767–777

    Article  CAS  PubMed  Google Scholar 

  • Freeman D, McManus S, Brugha T, Meltzer H, Jenkins R, Bebbington P (2011) Concomitants of paranoia in the general population. Psychol Med 41:923–936

    Article  CAS  PubMed  Google Scholar 

  • Fride E (2004) The endocannabinoid-CB receptor system: Importance for development and in pediatric disease. Neuro Endocrinol Lett 25:24–30

    CAS  PubMed  Google Scholar 

  • Friedman H, Eisenstein TK (2004) Neurological basis of drug dependence and its effects on the immune system. J Neuroimmunol 147:106–108

    Article  CAS  PubMed  Google Scholar 

  • Giedd J (2004) Structural Magnetic Resonance Imaging of the Adolescent Brain. Ann N Y Acad Sci 1021:77–85

    Article  PubMed  Google Scholar 

  • Huizink AC, Ferdinand RF, Ormel J, Verhulst FC (2006) Hypothalamic-pituitary-adrenal axis activity and early onset of cannabis use. Addiction 101:1581–1588

    Article  PubMed  Google Scholar 

  • Jaspan HB, Lawn SD, Safrit JT, Bekker LG (2006) The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescents. AIDS 20:483–494

    Article  PubMed  Google Scholar 

  • Johns LC, Cannon M, Singleton N, Murray RM, Farrell M, Brugha T, Bebbington P, Jenkins R, Meltzer H (2004) Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry 185:298–305

    Article  PubMed  Google Scholar 

  • Johnston LD, O’Maley PM, Bachman JG, Schulenberg JE (2012) Monitoring the Future national survey results on drug use, 1975–2011. In. Ann Arbor: Institute for Social Research, University of Michigan

  • Kessler DA, Natanblut SL, Wilkenfeld JP, Lorraine CC, Mayl SL, Bernstein IB, Thompson L (1997) Nicotine addiction: a pediatric disease. J Pediatr 130:518–524

    Article  CAS  PubMed  Google Scholar 

  • King G, Alicata D, Cloak C, Chang L (2010) Psychiatric symptoms and HPA axis function in adolescent methamphetamine users. J Neuroimmune Pharmacol 5:582–591

    Article  PubMed Central  PubMed  Google Scholar 

  • King GR, Ernst T, Deng W, Stenger A, Gonzales RM, Nakama H, Chang L (2011) Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels. J Neurosci 31:17923–17931

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H (2003) The cannabinoid system and immune modulation. J Leukoc Biol 74:486–496

    Article  CAS  PubMed  Google Scholar 

  • Koshibu K, Levitt P, Ahrens ET (2004) Sex-specific, postpuberty changes in mouse brain structures revealed by three-dimensional magnetic resonance microscopy. Neuroimage 22:1636–1645

    Article  PubMed  Google Scholar 

  • Lai HM, Sitharthan T (2012) Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia. Am J Drug Alcohol Abuse 38:567–574

    Article  PubMed  Google Scholar 

  • Marinelli M, Piazza PV (2002) Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci 16:387–394

    Article  PubMed  Google Scholar 

  • Monea A, Gruber R, Elod N, Beresescu G, Moldovn C, Monea M (2014) Saliva and serum levels of TNF-alpha and IL-6 in a sample of Romanian adult subjects with Type 2 diabetes mellitus and periodontal disease. Eur Sci J 10:350–359

    Google Scholar 

  • Moretti S, Castelli M, Franchi S, Raggi MA, Mercolini L, Protti M, Somaini L, Panerai AE, Sacerdote P (2014) Delta(9)-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood. J Leukoc Biol 96:523–534

    Article  PubMed  Google Scholar 

  • Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M (2009) Cannabinoids as novel anti-inflammatory drugs. Future Med Chem 1:1333–1349

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • O’Donovan A, Hughes BM, Slavich GM, Lynch L, Cronin MT, O’Farrelly C, Malone KM (2010) Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain Behav Immun 24:1074–1077

    Article  PubMed Central  PubMed  Google Scholar 

  • Paus T, Keshavan M, Giedd JN (2008) Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci 9:947–957

    CAS  PubMed Central  PubMed  Google Scholar 

  • Romeo RD (2010) Pubertal maturation and programming of hypothalamic-pituitary-adrenal reactivity. Front Neuroendocrinol 31:232–240

    Article  CAS  PubMed  Google Scholar 

  • Romeo RD, Sisk CL (2001) Pubertal and seasonal plasticity in the amygdala. Brain Res 889:71–77

    Article  CAS  PubMed  Google Scholar 

  • SAMHSA (2009) Results from the 2008 National survey on drug use and health: national findings. HHS, Rockville

    Google Scholar 

  • Sinha R (2008) Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 1141:105–130

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sjogren E, Leanderson P, Kristenson M, Ernerudh J (2006) Interleukin-6 levels in relation to psychosocial factors: studies on serum, saliva, and in vitro production by blood mononuclear cells. Brain Behav Immun 20:270–278

    Article  CAS  PubMed  Google Scholar 

  • Steiner MA, Wotjak CT (2008) Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Prog Brain Res 170:397–432

    CAS  PubMed  Google Scholar 

  • Tournier M, Sorbara F, Gindre C, Swendsen JD, Verdoux H (2003) Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population. Psychiatry Res 118:1–8

    Article  PubMed  Google Scholar 

  • Upadhyaya HP, Deas D, Brady KT, Kruesi M (2002) Cigarette smoking and psychiatric comorbidity in children and adolescents. J Am Acad Child Adolesc Psychiatry 41:1294–1305

    Article  PubMed  Google Scholar 

  • van Leeuwen AP, Creemers HE, Greaves-Lord K, Verhulst FC, Ormel J, Huizink AC (2011) Hypothalamic-pituitary-adrenal axis reactivity to social stress and adolescent cannabis use: the TRAILS study. Addiction 106:1484–1492

    Article  PubMed  Google Scholar 

  • Ventura J, Nuechterlein KH, Subotnik KL, Gutkind D, Gilbert EA (2000) Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Res 97:129–135

    Article  CAS  PubMed  Google Scholar 

  • Williamson S, Munro C, Pickler R, Grap MJ, Elswick RK Jr (2012) Comparison of biomarkers in blood and saliva in healthy adults. Nurs Res Pract 2012:246178

    PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to those who participated in this study. We also thank I. Chin MD and R Gonzales MS for coordinating participant visits and sample analyses, G King PhD for manuscript feedback, and C. Jiang MS for statistical consultation.

Grant Support

This study is jointly supported by the National Institutes of Health (NIH), Bethesda, MD): National Institute of Neurological Disorders and Stroke (2U54 NS039406 (to DA); U54 NS56883 (to L Chang)), National Institute on Drug Abuse (1 K24-DA016170 (to L Chang), K01-DA021203 (to C Cloak)), National Center for Research Resources (G12RR003061 & P20RR11091 (to T Ernst)), the Queen Emma Research Fund (to C Cloak) and the Hawaii Community Foundation Victoria S and Bradley L Geist Foundation (to C Cloak).

Disclosures

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christine C. Cloak.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cloak, C.C., Alicata, D., Ernst, T.M. et al. Psychiatric Symptoms, Salivary Cortisol and Cytokine Levels in Young Marijuana Users. J Neuroimmune Pharmacol 10, 380–390 (2015). https://doi.org/10.1007/s11481-015-9606-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-015-9606-0

Keywords

Navigation